---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-024562"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T22:32:08.966330+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences director Raymond Schinazi resigns from board, stays on SAB

## Summary
- Dr. Raymond Schinazi resigned from the Board effective Nov 5, 2022.
- He stepped down as Chair of Nominating and Governance Committee and from Compensation and Science/Technology Committees.
- Schinazi will continue serving on the company's Scientific Advisory Board.
- No successor named; Board plans to refresh with new independent directors.

## SEC filing metadata
- accession: 0000950170-22-024562
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017022024562/0000950170-22-024562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017022024562/dtil-20221105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-024562
- JSON: https://secwatch.observer/filing/0000950170-22-024562.json
- Plain text: https://secwatch.observer/filing/0000950170-22-024562.txt

## Key facts
- Executive change
  Raymond Schinazi resigned as Director at PRECISION BIOSCIENCES INC.
  - Action: resigned
  - Role: Director
  source text: On November 5, 2022, Dr. Raymond Schinazi informed the Board of Directors (the 'Board') of Precision BioSciences, Inc. (the 'Company' or 'Precision') that he was resigning from the Board, as well as his roles as Chair of the Board’s Nominating and Corporate Governance Committee and a member of the Board’s Compensation Committee and Science and Technology Committee, with immediate effect.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017022024562/0000950170-22-024562-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.